{
    "clinical_study": {
        "@rank": "58914", 
        "brief_summary": {
            "textblock": "To compare the efficacy and safety of orally administered didanosine (ddI) with orally\n      administered zidovudine (AZT) in the treatment of patients who exhibit increasing clinical\n      deterioration despite treatment with AZT."
        }, 
        "brief_title": "Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine", 
        "completion_date": {
            "#text": "April 1992", 
            "@type": "Actual"
        }, 
        "condition": "HIV Infections", 
        "condition_browse": {
            "mesh_term": [
                "Acquired Immunodeficiency Syndrome", 
                "HIV Infections", 
                "AIDS-Related Complex"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria\n\n        Concurrent Medication:\n\n        Allowed for Hematologic toxicity:\n\n          -  Erythropoietin.\n\n          -  Colony-Stimulating Factors.\n\n          -  Allowed for prophylaxis of Pneumocystis carinii pneumonia (PCP):\n\n          -  Aerosolized pentamidine.\n\n          -  Trimethoprim/sulfamethoxazole.\n\n          -  Dapsone.\n\n          -  NOTE:\n\n          -  If intravenous pentamidine is required for treatment of PCP, study drug should be\n             suspended until one week after completion of intravenous pentamidine.\n\n          -  Allowed:\n\n          -  Prophylactic or suppressive therapy begun prior to study entry with the exception of\n             neurotoxic agents (as defined in the protocol).\n\n        Concurrent Treatment:\n\n        Allowed:\n\n          -  Transfusions for hematologic toxicity.\n\n        Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following conditions or symptoms are excluded:\n\n          -  Active acute AIDS defining infection.\n\n          -  Clinical evidence of acute pancreatitis in the last two years or chronic\n             pancreatitis.\n\n          -  Dementia of such severity that patient cannot give informed consent.\n\n          -  Grade 2 or worse peripheral neuropathy as defined by Targeted Neuropathy Score\n             (Schaumberg).\n\n          -  Prior Cytomegalovirus disease requiring ongoing systemic ganciclovir therapy.\n\n          -  Extensive Kaposi's sarcoma or other malignancy requiring systemic cytotoxic\n             myelosuppressive or neurotoxic chemotherapy.\n\n          -  Cardiomyopathy or the need for antiarrhythmic therapy.\n\n          -  Inability to tolerate at least 600 mg per day of zidovudine (AZT).\n\n          -  Seizures within the last 6 months or the need for anticonvulsant therapy.\n\n        Concurrent Medication:\n\n        Excluded:\n\n          -  Ganciclovir (DHPG).\n\n          -  Myelosuppressive or neurotoxic chemotherapy.\n\n          -  Antiarrhythmic therapy.\n\n          -  Anticonvulsant therapy.\n\n          -  Neurotoxic agents (as defined in the protocol).\n\n          -  NOTE:\n\n          -  If intravenous pentamidine is required for treatment of Pneumocystis carinii\n             pneumonia (PCP), study drug should be suspended until 1 week after completion of\n             intravenous pentamidine.\n\n        Patients with the following are excluded:\n\n          -  Symptoms and conditions defined in the Patient Exclusion Co-Existing Conditions\n             field.\n\n          -  Average of two sequential CD4 counts from SciCor Clinical Laboratories in the 30 days\n             prior to study entry > 300 cells/mm3.\n\n        Prior Medication:\n\n        Excluded, participation in studies using:\n\n          -  Dideoxyinosine (ddI).\n\n          -  2',3'-Dideoxy-2',3'-didehydrothymidine (d4T).\n\n          -  Dideoxycytidine (ddC).\n\n          -  Excluded within one month of study entry:\n\n          -  Any other experimental antiretroviral compounds.\n\n        Patients must:\n\n          -  Have documented HIV positivity via ELISA.\n\n          -  Meet CDC criteria for AIDS or AIDS related complex (ARC).\n\n          -  Have received zidovudine (AZT) for = or > 6 months and tolerated a dose of at least\n             500 mg per day without significant hematologic toxicity.\n\n          -  Have no acute AIDS defining opportunistic infection, but may be receiving suppressive\n             therapy for such infections.\n\n          -  Demonstrate at least one of the following criteria for clinical deterioration despite\n             AZT therapy within 4 weeks prior to study entry (8 weeks prior for weight loss):\n\n          -  involuntary weight loss of more than 5 percent of the body weight occurring over the\n             8 week period prior to study entry, Karnofsky score = or > 50 but demonstrating a\n             fall = or > 20 from previous level of functioning (assessment must be persistent on\n             two occasions at least 14 days apart), unexplained fever of = or > 38 degrees C\n             (despite evaluation defined in protocol) for more than 7 days, appearance of newly\n             diagnosed oral hairy leukoplakia or oral candidiasis, or recurrence of a previously\n             quiescent multidermatomal varicella-zoster, appearance of dermatologic afflictions\n             (e.g. psoriasis, molluscum contagiosum, or newly diagnosed seborrheic dermatitis),\n             appearance of chronic herpetic ulcers not responsive to acyclovir therapy.\n\n        Required:\n\n          -  Zidovudine (AZT) for = or > 6 months prior to study entry."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "12 Years"
        }, 
        "enrollment": "300", 
        "firstreceived_date": "November 2, 1999", 
        "id_info": {
            "nct_id": "NCT00002035", 
            "org_study_id": "039B", 
            "secondary_id": "AI454-010"
        }, 
        "intervention": [
            {
                "intervention_name": "Zidovudine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "Didanosine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Didanosine", 
                "Zidovudine"
            ]
        }, 
        "keyword": [
            "Didanosine", 
            "Acquired Immunodeficiency Syndrome", 
            "AIDS-Related Complex", 
            "Zidovudine"
        ], 
        "lastchanged_date": "August 4, 2011", 
        "link": [
            {
                "description": "BMS Clinical Trials Disclosure", 
                "url": "http://ctr.bms.com/ctd/start.do"
            }, 
            {
                "description": "For FDA Safety Alerts and Recalls refer to the following link www.fda.gov/MEDWATCH/safety.htm", 
                "url": "http://www.fda.gov/MEDWATCH/safety.htm"
            }
        ], 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Tucson", 
                        "country": "United States", 
                        "state": "Arizona", 
                        "zip": "85724"
                    }, 
                    "name": "Univ of Arizona / Health Science Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Haven", 
                        "country": "United States", 
                        "state": "Connecticut", 
                        "zip": "06510"
                    }, 
                    "name": "Yale Univ Med School"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Fort Lauderdale", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33316"
                    }, 
                    "name": "G E Morey Jr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32806"
                    }, 
                    "name": "VP Med Services / HHCS Research Institute Inc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Atlanta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30308"
                    }, 
                    "name": "AIDS Research Consortium of Atlanta"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hines", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60141"
                    }, 
                    "name": "Edward Hines Veterans Administration Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Wichita", 
                        "country": "United States", 
                        "state": "Kansas", 
                        "zip": "67214"
                    }, 
                    "name": "Univ of Kansas School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Detroit", 
                        "country": "United States", 
                        "state": "Michigan", 
                        "zip": "48201"
                    }, 
                    "name": "Harper Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Albany", 
                        "country": "United States", 
                        "state": "New York", 
                        "zip": "12203"
                    }, 
                    "name": "Albany Med College / AIDS Treatment Ctr"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toledo", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "43699"
                    }, 
                    "name": "Med College of Ohio"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Philadelphia", 
                        "country": "United States", 
                        "state": "Pennsylvania", 
                        "zip": "19104"
                    }, 
                    "name": "Univ of Pennsylvania / HIV Clinic"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Dallas", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75235"
                    }, 
                    "name": "Univ of Texas Southwestern Med Ctr of Dallas"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Galveston", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "775550882"
                    }, 
                    "name": "Univ TX Galveston Med Branch"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78284"
                    }, 
                    "name": "Audie L Murphy Veterans Administration Hosp"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84132"
                    }, 
                    "name": "Univ of Utah School of Medicine"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hampton", 
                        "country": "United States", 
                        "state": "Virginia", 
                        "zip": "23666"
                    }, 
                    "name": "Dr Stephen L Green"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milwaukee", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53226"
                    }, 
                    "name": "Milwaukee County Med Complex"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Juan", 
                        "country": "Puerto Rico", 
                        "zip": "009275800"
                    }, 
                    "name": "UPR School of Medicine"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Puerto Rico"
            ]
        }, 
        "official_title": "Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine", 
        "overall_official": {
            "affiliation": "Bristol-Myers Squibb", 
            "last_name": "Bristol-Myers Squibb", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "reference": {
            "citation": "Ruedy N, et al. Results of long term follow-up of a double blind study of ddI vs continued AZT among individuals with CD4s 200-500/mm3. Int Conf AIDS. 1994 Aug 7-12;10(2):16 (abstract no 358B)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002035"
        }, 
        "source": "Bristol-Myers Squibb", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Bristol-Myers Squibb", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Endpoint Classification: Safety Study, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2011"
    }, 
    "geocoordinates": {
        "AIDS Research Consortium of Atlanta": "33.749 -84.388", 
        "Albany Med College / AIDS Treatment Ctr": "42.653 -73.756", 
        "Audie L Murphy Veterans Administration Hosp": "29.424 -98.494", 
        "Dr Stephen L Green": "37.03 -76.345", 
        "Edward Hines Veterans Administration Hosp": "41.854 -87.84", 
        "G E Morey Jr": "26.122 -80.143", 
        "Harper Hosp": "42.331 -83.046", 
        "Med College of Ohio": "41.664 -83.555", 
        "Milwaukee County Med Complex": "43.039 -87.906", 
        "UPR School of Medicine": "18.466 -66.106", 
        "Univ TX Galveston Med Branch": "29.301 -94.798", 
        "Univ of Arizona / Health Science Ctr": "32.222 -110.926", 
        "Univ of Kansas School of Medicine": "37.692 -97.337", 
        "Univ of Pennsylvania / HIV Clinic": "39.952 -75.164", 
        "Univ of Texas Southwestern Med Ctr of Dallas": "32.803 -96.77", 
        "Univ of Utah School of Medicine": "40.761 -111.891", 
        "VP Med Services / HHCS Research Institute Inc": "28.538 -81.379", 
        "Yale Univ Med School": "41.308 -72.928"
    }
}